1-9 of 9
Mansi R. Shah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Efficacy of Teclistamab in Multiple Myeloma Patients with Secondary Plasma Cell Leukemia

Asis Shrestha, Sharmilan Thanendrarajan, Aishee Bag, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Suzanne Lentzsch, Frits van Rhee, Anita D'Souza, Rajshekhar Chakraborty, Nishi Shah, Mansi R. Shah, Meera Mohan, Carolina Schinke
Journal: Blood
Blood (2024) 144 (Supplement 1): 6994.
https://doi.org/10.1182/blood-2024-210478
Published: 2024
Journal Articles

Effects of Intravenous Immunoglobulin Supplementation (IVIG) on Infections in Recipients of Teclistamab Therapy for Multiple Myeloma (MM): A Multi-Institutional Study

Heloise Cheruvalath, Anna Clennon, Asis Shrestha, Aniko Szabo, Vineel Bhatlapenumarthi, Anannya Patwari, Metodi Balev, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Anup Kumar Trikannad, Sruthi Vellanki, Samer Al Hadidi, Suzanne Lentzsch, Frits van Rhee, Mansi R. Shah, Aishee Bag, Anita D'Souza, Rajshekhar Chakraborty, Nishi Shah, Carolina Schinke, Meera Mohan
Journal: Blood
Blood (2024) 144 (Supplement 1): 256.
https://doi.org/10.1182/blood-2024-199374
Published: 2024
Journal Articles

Prevalent Treatment Patterns of Teclistamab and Talquetamab for Multiple Myeloma (MM): Experience from 609 Patients

Farheen Chunara, Mansi R. Shah, Nishi Shah, Jessica Kent, Ghulam Rehman Mohyuddin, Sabarinath V Radhakrishnan, Gurbakhash Kaur, Rajshekhar Chakraborty, Leo Rasche, Carolina Schinke, Anita D'Souza, Aniko Szabo, Meera Mohan
Journal: Blood
Blood (2024) 144 (Supplement 1): 2394.
https://doi.org/10.1182/blood-2024-201599
Published: 2024
Journal Articles

Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma: Longer Follow-up and Selected High-Risk Subgroup Analyses of the Linker-MM1 Study

Mansi R. Shah, Joshua Richter, Hans C. Lee, Attaya Suvannasankha, James E. Hoffman, Suzanne Lentzsch, Sundar Jagannath, Jeffrey A. Zonder, Rachid Baz, Swathi Namburi, Ka Lung Wu, Madhav V. Dhodapkar, Joseph J. Maly, Rebecca Silbermann, Chang-Ki Min, Matthew Pianko, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez-Lopez, Michelle DeVeaux, Dhruti Chokshi, Megan Seraphin, Anita Boyapati, Anasuya Hazra, Glenn S. Kroog, Kate Knorr, Naresh Bumma
Journal: Blood
Blood (2024) 144 (Supplement 1): 3369.
https://doi.org/10.1182/blood-2024-199733
Published: 2024
Journal Articles

Efficacy and Safety of Teclistamab in Relapsed Refractory Multiple Myeloma: Long-Term Follow-up from a Real World Multi-Institutional Cohort

Metodi Balev, Nishi Shah, Mansi R. Shah, Anannya Patwari, Aniko Szabo, Anita D'Souza, Asis Shrestha, Binod Dhakal, Danny Luan, Dennis L Cooper, Frits van Rhee, Heloise Cheruvalath, Jorge Monge, Mark Forsberg, Maurizio Zangari, Sharmilan Thanendrarajan, Vineel Bhatlapenumarthi, Samer Al-Hadidi, Suzanne Lentzsch, Divaya Bhutani, Rajshekhar Chakraborty, Carolina Schinke, Meera Mohan
Journal: Blood
Blood (2024) 144 (Supplement 1): 3781.
https://doi.org/10.1182/blood-2024-203609
Published: 2024
Journal Articles

Health-Related Quality of Life (HRQoL) Among Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Linvoseltamab in Linker-MM1: Interim Assessment up to 36 Weeks of Treatment

James E. Hoffman, Naresh Bumma, Joshua Richter, Madhav V. Dhodapkar, Hans C. Lee, Attaya Suvannasankha, Christiane A. Houde, Joseph J. Maly, Mansi R. Shah, Rachid Baz, Swathi Namburi, Ka Lung Wu, Matthew Pianko, Jing Christine Ye, Suzanne Lentzsch, Rebecca Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez Lopez, Michelle DeVeaux, Cristina Ivanescu, Karen Rodriguez Lorenc, Glenn S. Kroog, Yariv Houvras, Timothy J. Inocencio, Lei Chi, James Harnett, Qiufei Ma, Sundar Jagannath
Journal: Blood
Blood (2023) 142 (Supplement 1): 3359.
https://doi.org/10.1182/blood-2023-179170
Published: 2023
Journal Articles

Patterns of Response to 200 Mg Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma: Longer Follow-Up of the Linker-MM1 Study

Sundar Jagannath, Joshua Richter, Madhav V. Dhodapkar, James E. Hoffman, Hans C. Lee, Attaya Suvannasankha, Mansi R. Shah, Suzanne Lentzsch, Jeffrey A. Zonder, Rachid Baz, Joseph J. Maly, Swathi Namburi, Ka Lung Wu, Matthew Pianko, Jing Christine Ye, Rebecca Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez Lopez, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, Karen Rodriguez Lorenc, Glenn S. Kroog, Yariv Houvras, Naresh Bumma
Journal: Blood
Blood (2023) 142 (Supplement 1): 4746.
https://doi.org/10.1182/blood-2023-177968
Published: 2023
Journal Articles

Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study

Naresh Bumma, Joshua Richter, Jason Brayer, Jeffrey A. Zonder, Madhav Dhodapkar, Mansi R. Shah, James E. Hoffman, Raya Mawad, Joseph J. Maly, Suzanne Lentzsch, Attaya Suvannasankha, Pourab Roy, Jyotirmoy Dey, Dhruti Chokshi, Anita Boyapati, Jenn Visich, Yariv Houvras, Karen Rodriguez Lorenc, Glenn S. Kroog, Sundar Jagannath
Journal: Blood
Blood (2022) 140 (Supplement 1): 10140–10141.
https://doi.org/10.1182/blood-2022-159969
Published: 2022
Journal Articles

Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings

Mansi R Shah, MD, Imraan Jan, DO, Jeremy Johns, MD, Kuldip Singh, MD, Pallavi Kumar, MD, Norma Belarmino, MHSA, Kara Saggiomo, MSN, Carolyn Hayes, RN, PhD, Deborah Toppmeyer, MD, Kimyatta Washington, MHSA, Bruce Haffty, MD, Steven Libutti, MD, Andrew M. Evens, DO,MMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-136396
Published: 2020